Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access

Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis

Lisa Carroll, Ian H Frazer, Malcolm Turner, Thomas H Marwick and Ranjeny Thomas*

Arthritis Research & Therapy 2007, 9:R39 doi:10.1186/ar2175

Accesses  

  • Last 30 days: 55 accesses
  • Last year: 498 accesses
  • All time: 3692 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

Yueh-Sheng Chen, Weixing Yan, Carolyn L Geczy, Matthew A Brown, Ranjeny Thomas Arthritis Research & Therapy 2009, 11:R39 (11 March 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation

Suad Hannawi, Brian Haluska, Thomas H Marwick, Ranjeny Thomas Arthritis Research & Therapy 2007, 9:R116 (6 November 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | Editor’s summary

Early rheumatoid arthritis patients show increased atherosclerotic burden compared to controls; inflammation may promote the development of atherosclerotic disease well before the first symptoms of joint disease appear.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations